FIRENCT03772743
Functional Assessment in Elderly MI Patients With Multivessel Disease
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 14 versions: 14 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 10 words Show 5 more changesShow less
- Trial completed
- Study completion date changed from estimate of Oct 3, 2026 to Nov 16, 2026
- Study description revised
- Site details revised at 3 of 37 sites
- Publications: 14 to 13
- Study Identification, Study Status, Oversightv13
- Minor Site details revised at 5 of 37 sitesv12
- Minor Secondary endpoints: 7 to 23v11
- Minor Study sites: 29 to 37v10
Show 8 earlier versionsHide 8 earlier versions
- Minor Primary completion date changed from estimate of Oct 2022 to Oct 30, 2022
- Study completion date: Sep 2026 to Oct 3, 2026
- Minor Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 1385 to confirmed 1445
- Primary completion date: Sep 2022 to Oct 2022
- Site details revised at 29 of 29 sites
- Notable Primary completion date: Dec 2021 to Sep 2022
- Study completion date: Dec 2025 to Sep 2026
- Publications: details revised at 1 of 14 entries
- Notable Eligibility criteria expanded, about 8 words
- Secondary endpoints: 2 to 7
- Site details revised at 8 of 29 sites
- Minor Study sites: 16 to 29
- Study description expanded, about 878 words
- Minor Study sites: 15 to 16v4
Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
- Study sites: 0 to 15
- Primary completion date: Jun 2021 to Dec 2021
- Study completion date: Jun 2025 to Dec 2025
- Start date changed from estimate of Jun 1, 2019 to Jul 15, 2019
- Notable Start date: Feb 2019 to Jun 1, 2019v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (10)
Show 5 moreShow less
Arms and interventions
All patients randomized to culprit only revascularization must not undergo percutaneous coronary intervention (PCI) any lesion except from the culprit lesion already treated at the moment of the randomization. Staged procedures are considered protocol violation.
Patients who are randomized to this strategy will receive revascularization of the culprit lesion and guided by functional assessment on all non-culprit lesions. Functional evaluation is mandatory for all stenosis with diameter stenosis % between 50 and 90% at visual estimation. Revascularization must be guided by functional assessment on all vessels. The system utilized to obtain functional evaluation is left to Operator's discretion. PCI is allowed only if functional evaluation is positive according to the threshold of the chosen functional system. It is suggested to achieve functional complete revascularization within the index procedure, while it is mandatory to obtain it within the index hospitalization.
Other: Culprit-only revascularization, Complete functionally-guided revascularization
Sites
37 sites in 3 countries
Italy 22, Spain 10, Poland 5